Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Knappertz Volker
EVP, Research and Development at Aurinia Pharmaceuticals. Filing since 20 Feb 2024.
CIK 0001754122
Company
Date
Role
Action
Shares
Amount
Of holding
AUPH
Aurinia Pharmaceuticals Inc.
27 Feb 2024
EVP, Research and Development
Sold at will
4,930
$30.07K
1.5%
AUPH
Aurinia Pharmaceuticals Inc.
20 Feb 2024
EVP, Research and Development
Sold at will
25,146
$137.80K
7.2%
2 decisions on file.
